Science & Research · All reports

Science & ResearchResearch paperSource analysis

Keeping patient data local does not make an AI health claim causal

A peer-reviewed methods review maps how hospitals can estimate treatment effects without pooling patient records. Its central warning is practical: federation changes computation, not the assumptions needed for a causal conclusion or a real privacy guarantee.

By The Impact of AI Editorial Desk•Released 18 October 2026 at 03:00 BST•3 min full report · 1 min summary•1 source · view evidence

The short version

What happened
The structured review separates three questions often blurred together: the treatment effect being estimated, the distributed-computation protocol and the privacy mechanism.
Who it affects
Federation may let more hospitals contribute evidence without exporting patient-level records, but patients can still be harmed by biased treatment estimates or vague privacy claims if clinical differences and threat models are ignored.
What remains unproven
Structured targeted review rather than a systematic review or meta-analysis; no reported count of screened and retained studies; no new patient data, pooled clinical outcome or comparative benchmark; several cited methods remain preprints.

Keep in mind

Structured targeted review rather than a systematic review or meta-analysis; no reported count of screened and retained studies; no new patient data, pooled clinical outcome or comparative benchmark; several cited methods remain preprints.

Source analysis · 1 linked source. Primary analysed source date: 17 October 2026.

Read the full report · 3 min The evidence, methods, implications and limitations

Three layers determine whether a result deserves trust

The review organises federated causal inference around an inferential target, a computation protocol and a privacy mechanism. That distinction matters: hospitals can exchange approved statistics or model updates without sharing raw records, yet still estimate the wrong treatment effect if sites define patients, treatments, outcomes or time zero differently.

The authors cover binary, continuous and time-to-event outcomes, comparing one-shot, iterative, personalised, peer-to-peer and model-decomposition strategies. They only describe a federated estimate as equivalent or close to pooled analysis when a cited method establishes that result under explicit conditions.[1]

Why local data is neither causal proof nor automatic privacy

A treatment-effect claim still needs a defined intervention and target population, adequate adjustment for confounding, compatible measurements, positivity and suitable handling of censoring. Averaging site estimates can target the wrong population, and a distributed Cox regression is not automatically a causal survival analysis.

Privacy is a separate test. Secure aggregation can hide each site’s contribution while revealing an approved total, but it does not limit everything inferable from the result. Differential privacy gives a quantified guarantee only under a specified neighbouring relation and privacy budget; merely sending gradients can still expose information.[1]

The distinction that matters

Three questions before trusting a federated health estimate

Distributed computation solves only one part of a multi-site causal study.

Target

Define treatment, outcome and population

Know which causal effect is being estimated

Compute

Exchange approved summaries or updates

Avoid centralising patient-level records

Protect

Specify secure aggregation or differential privacy

State what is protected and from whom

A technically federated analysis can still answer the wrong question or provide an incomplete privacy guarantee. Source: npj Artificial Intelligence

What changes for research teams and patients

Federated analysis can make some multi-hospital studies feasible where legal, governance or practical barriers prevent central pooling. Patients and clinicians still need the resulting estimate to match the decision at hand, and institutions need an explicit threat model rather than a generic claim that data stayed local.

The field needs realistic benchmarks with known treatment effects and cross-site differences, stronger tests of privacy–utility trade-offs, auditable software and validation under site inclusion, data drift and demographic heterogeneity. The review itself is structured and targeted, not systematic, and reports no new clinical effectiveness result.[1]

Continue the story

Read next

All reports

Continue exploring federated learning: compare the finding and its evidence limits.

Can hospitals study dementia-drug signals without sharing patient records? A federated method matched pooled estimates—but did not prove treatments work

FLAT-WHITE reproduced centralized estimates from four US health-data networks using one exchange of summary statistics. Twenty-one drug associations also appeared in a 339,180-person external cohort, but residual confounding means none is a treatment recommendation.

Read the next report
Explore the full source and evidence record

What this means for people

  • Federation may let more hospitals contribute evidence without exporting patient-level records, but patients can still be harmed by biased treatment estimates or vague privacy claims if clinical differences and threat models are ignored.

Global context

The methods are intended for distributed health systems globally, but governance, coding, population mix and data quality vary by institution and country. Federation does not make those differences disappear.

What the evidence does not yet show

  • Structured targeted review rather than a systematic review or meta-analysis; no reported count of screened and retained studies; no new patient data, pooled clinical outcome or comparative benchmark; several cited methods remain preprints.

What to watch next

  • Open benchmarks with controlled heterogeneity, prospective multi-system applications, explicit privacy budgets and threat models, and evidence that federated estimates remain stable and clinically useful across sites.

Living evidence record

Impact record IAI-07P6K2P

Explore the full tracker

Evidence stage

Studied

Confidence

Supported

Reporting basis

Source analysis

Independent or research support

Present

Record status

Monitoring

Last checked

18 October 2026

Source trail

1 direct source across 1 source type.

People impact

Documented in this record.

Uncertainty

Limits and next checks are explicit.

Stages describe the evidence available—not whether a technology is good or bad. See the public method.

Single-source reporting disclosure

This record analyses one direct source. It can establish what npj Artificial Intelligence published or reported, but it is not independent corroboration of every performance claim or predicted outcome. The confidence label will change only when broader evidence is added.

Evidence trail

Sources used for this report

Links checked 18 October 2026

1npj Artificial Intelligence• Research paper• 17 October 2026• United StatesFederated causal inference for effect estimation in healthcare: methods, challenges, and applicationsPeer-reviewed, citable early review (DOI: 10.1038/s44387-026-00168-1). The authors report no external funding and no competing interests. It is a structured targeted review, not a systematic review or meta-analysis.
Research question, topics and regions

What federated methods can and cannot establish when healthcare institutions estimate treatment effects without centralising patient-level data

Topics: Federated learning · Causal inference · Health data · Privacy · Real-world evidence

Regions: United States · Global

This report is labelled source analysis. We summarise and analyse source material in our own words; company statements remain attributed claims until independently supported. Translated summaries preserve the meaning of the original source and link back to it. Read our editorial standards.